home / stock / rbgly / rbgly articles
Abbott Laboratories (NYSE:ABT) is set to face trial on Monday over allegations that its formula for preterm infants used in neonatal intensive care...
Investors can contact the law firm at no cost to learn more about recovering their losses ?LOS ANGELES, March 15, 2024 (GLOBE NEWSWIRE) -- The...
An Illinois jury has issued a verdict compelling Reckitt Benckiser Group Plc’s (OTC:RBGLY) (OTC:RBGPF) Mead Johnson to pa...
A massive recall of hypoallergenic infant formula has been initiated due to concerns over potential bacteria contamination. The recall involves app...
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several l...
News, Short Squeeze, Breakout and More Instantly...
Reckitt Benckiser Group Plc ADR Company Name:
RBGLY Stock Symbol:
OTCMKTS Market:
Reckitt Benckiser Group Plc ADR Website:
Klepierre (KLPEF) is expected to report for Q4 2023 comScore Inc. (SCOR) is expected to report $0.8 for Q4 2023 Universal Stainless & Alloy Products Inc. (USAP) is expected to report for Q4 2023 FAT Brands Inc. (FAT) is expected to report $-1.55 for Q4 2023 Jet.AI Inc. (JTAI) ...
Reckitt Benckiser Group Plc ADR (RBGLY) is expected to report for Q4 2023